Institute of Health Information and Statistics of the Czech Republic
17
11
11
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 17 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
The Combined First Trimester Screening
Role: lead
Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care
Role: lead
Early Detection of Developmental Abnormalities of Preterm Infants at 5 Years of Age
Role: lead
Early Detection of OAB and Elimination of Negative Impact on Quality of Life
Role: lead
Protocol-driven Nutrition in Preterm Infants
Role: lead
Early Detection of CTEPH in Patients After APE
Role: lead
Controlled Remote Monitoring and Optimization of Oxygen Therapy in Preterm Infants
Role: lead
Prostate Cancer Awareness and Initiative for Screening in the European Union
Role: collaborator
National Childhood Obesity Prevention Programme BE FIT 24
Role: lead
Early Detection of HCV in Injection Drug Users
Role: lead
Versatile Ampification Single-Molecule Detection in Liquid Biopsy
Role: collaborator
Early Detection of Malnutrition in Oncology Patients and Elderly Patients
Role: lead
Pilot Project of Familial Hypercholesterolemia Screening in Newborns in the Czech Republic
Role: lead
COVID-19: SARS-CoV-2-CZ-PREVAL-II Study
Role: lead
Mapping Health-related Quality of Life in Pregnant Women With Thyroid Disease.
Role: collaborator
Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity)
Role: lead
COVID-19: Herd Immunity Study in the Czech Republic
Role: lead
All 17 trials loaded